Romnee Clark

  • 299 Citations
  • 11 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Romnee Clark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Pemetrexed Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Folic Acid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1999 2019

CANCER CENTER SUPPORT GRANT

Zhang, Z., Clark, R., Perkins, S., Abonour, R., Srour, E., Dunn, K., Loehrer, P., Yiannoutsos, C., Field, L., Williams, S., Croop, J., Williams, D., Hawes, J., Jung, S., Cripe, L. & Cripe, L.

National Institutes of Health

9/22/998/31/19

Project: Research project

Neoplasms
Research Personnel
Research
Biostatistics
Flow Cytometry

Publications 1994 2016

  • 299 Citations
  • 11 h-Index
  • 12 Article
3 Citations (Scopus)

Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

Research output: Contribution to journalArticle

Inpatients
Hepatocellular Carcinoma
Immunologic Factors
Bilirubin
Survival
18 Citations (Scopus)

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer

Chiorean, E. G., Schneider, B., Akisik, M., Perkins, S., Anderson, S., Johnson, C. S., DeWitt, J., Helft, P., Clark, R., Johnston, E. L., Spittler, A. J., Deluca, J., Bu, G., Shahda, S., Loehrer, P., Sandrasegaran, K. & Cardenes, H. R., Jun 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 2, p. 284-291 8 p.

Research output: Contribution to journalArticle

gemcitabine
Chemoradiotherapy
Pancreatic Neoplasms
radiation therapy
Radiotherapy
13 Citations (Scopus)

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Chiorean, E. G., Sanghani, S., Schiel, M. A., Yu, M., Burns, M., Tong, Y., Hinkle, D. T., Coleman, N., Robb, B., Leblanc, J., Clark, R., Bufill, J., Curie, C., Loehrer, P. & Cardenes, H., Jul 2012, In : Cancer Chemotherapy and Pharmacology. 70, 1, p. 25-32 8 p.

Research output: Contribution to journalArticle

irinotecan
Chemoradiotherapy
Oncology
Rectal Neoplasms
Gene expression
16 Citations (Scopus)

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I/II study from the hoosier oncology group

Jalal, S., Waterhouse, D., Edelman, M. J., Nattam, S., Ansari, R., Koneru, K., Clark, R., Richards, A., Wu, J., Yu, M., Bottema, B., White, A. & Hanna, N., Nov 2009, In : Journal of Thoracic Oncology. 4, 11, p. 1420-1424 5 p.

Research output: Contribution to journalArticle

Pemetrexed
Non-Small Cell Lung Carcinoma
Disease Progression
Maximum Tolerated Dose
Survival
24 Citations (Scopus)

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer

Llombart-Cussac, A., Martin, M., Harbeck, N., Anghel, R. M., Eniu, A. E., Verrill, M. W., Neven, P., De Grève, J., Melemed, A. S., Clark, R., Simms, L., Kaiser, C. J. & Ma, D., Jun 15 2007, In : Clinical Cancer Research. 13, 12, p. 3652-3659 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Breast Neoplasms
Drug Therapy
Confidence Intervals
Vitamin B 12